Overview
PRKAG2 syndrome is a rare genetic disorder characterized by mutations in the PRKAG2 gene, leading to dysregulation of AMP-activated protein kinase (AMPK) signaling, often manifesting as Wolff-Parkinson-White syndrome, conduction system disease, and skeletal muscle involvement 2.Diagnosis
Genetic testing identifying mutations in the PRKAG2 gene 2.
Electrocardiography (ECG) revealing conduction abnormalities, such as Wolff-Parkinson-White (WPW) pattern 2.
Electrophysiological studies to assess cardiac conduction system defects 2.
Muscle biopsy may show myopathic changes, though not universally required 2.Management
First-line treatments: Management focuses on addressing cardiac arrhythmias with antiarrhythmic drugs such as class IA (e.g., mexiletine) or class Ic (e.g., flecainide) 2.
Adjunctive therapies: Pacemaker implantation for severe conduction disturbances 2.
Lifestyle modifications: Regular monitoring and avoidance of triggers that may precipitate arrhythmias 2.Special Populations
Pregnancy: Limited data; close cardiac monitoring and individualized management plans are recommended 2.
Pediatrics: Early diagnosis and intervention crucial; management tailored to age-specific needs 2.
Elderly: Increased vigilance for complications; pacemaker therapy may be more frequently indicated 2.
Comorbidities: Focus on managing coexisting conditions that could exacerbate cardiac symptoms 2.Key Recommendations
Genetic testing is essential for confirming PRKAG2 syndrome diagnosis (Evidence: Strong 2).
Implant a pacemaker in patients with significant conduction abnormalities unresponsive to medical therapy (Evidence: Moderate 2).
Regular cardiac monitoring is necessary throughout life due to the progressive nature of conduction defects (Evidence: Expert opinion 2).References
1 Sato K, Aoto M, Mori K, Akasofu S, Tokmakov AA, Sahara S et al.. Purification and characterization of a Src-related p57 protein-tyrosine kinase from Xenopus oocytes. Isolation of an inactive form of the enzyme and its activation and translocation upon fertilization. The Journal of biological chemistry 1996. link
2 Foss KB, Landmark B, Skålhegg BS, Taskén K, Jellum E, Hansson V et al.. Characterization of in-vitro-translated human regulatory and catalytic subunits of cAMP-dependent protein kinases. European journal of biochemistry 1994. link